CHLORPHENIRAMINE POLISTIREX

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

13 Suppliers, 6 USDMF, 1 CEP/COS, 4 EU WC, 2 KDMF, 3 NDC API, 8 Listed Suppliers

DOSSIERs // Finished Dosage Forms

22 Dossiers, 14 FDA Orange Book, 2 Europe, 3 South Africa, 3 Listed Dossiers

DRUG PRODUCT COMPOSITION

SUSPENSION, EXTENDED RELEASE;ORAL - EQ 8MG MALEATE/5ML;EQ 10MG BITARTRATE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2.8MG BASE/5ML;EQ 14.7MG BASE/5ML, SYRUP;ORAL - 2MG/5ML

RELATED EXCIPIENT COMPANIES

Suppliers, 19 Kerry, 18 Roquette, 10 Microlex e.U, 9 Sigachi Industries, 9 Gangwal Healthcare, 7 Gangwal Chemicals, 7 BASF, 7 Boai NKY Pharmaceuticals Ltd, 6 Actylis, 4 DFE Pharma, 4 Rochem International Inc, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 DKSH, 3 SPI Pharma, 3 Nanjing Well Pharmaceutical, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Pharmatrans-Sanaq, 2 Pharm-RX Chemical, 2 Prachin Chemical, 2 Vasa Pharmachem, 2 Ulanqab Kema New Material, 1 Zhejiang Huakang Pharmaceutical, 1 Pfanstiehl, 1 Bioplus Life Sciences, 1 Finar, 1 Ideal Cures Pvt Ltd, 1 Alcedo Pharmachem, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Shanghai Welltone Material Technology Co., Ltd

EXCIPIENTS BY APPLICATIONS

48 Fillers, Diluents & Binders, 23 Direct Compression, 17 Thickeners and Stabilizers, 17 Disintegrants & Superdisintegrants, 13 Co-Processed Excipients, 13 Film Formers & Plasticizers, 13 Granulation, 13 Taste Masking, 12 Lubricants & Glidants, 11 Coating Systems & Additives, 7 Controlled & Modified Release, 7 Chewable & Orodispersible Aids, 6 Parenteral, 5 Solubilizers, 3 API Stability Enhancers, 3 Topical, 2 Emulsifying Agents, 1 Soft Gelatin, 1 Rheology Modifiers